Showing results (81-90 of 147) with videos related to
Sort By:
Pageof 15
Journal of Alzheimer'S Disease : JAD|March 1, 2016
Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy BodiesNicolas R Barthélemy, Audrey Gabelle, Christophe Hirtz, et al.European Journal of Neurology|April 8, 2023
Serum neurofilament light chain cut-off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosisMehdi Brousse, Constance Delaby, Elisa De La Cruz, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|December 29, 2015
Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typingChristophe Hirtz, Jerome Vialaret, Georges Nouadje, et al.Biomacromolecules|October 23, 2024
Ultrasensitive In Vitro and Ex Vivo Tracking of 13C-Labeled PEG-PLA Degradation Products by MALDI-TOF Mass SpectrometryMinh-Thuong Khong, Vincent Darcos, Jérôme Vialaret, et al.Journal of Cell Communication and Signaling|March 24, 2019
Bystander effectors of chondrosarcoma cells irradiated at different LET impair proliferation of chondrocytesCharlotte Lepleux, Aurélie Marie-Brasset, Mihaela Temelie, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|February 16, 2022
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profilesConstance Delaby, Daniel Alcolea, Christophe Hirtz, et al.Molecular Neurodegeneration|October 8, 2024
Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer diseaseSylvain Lehmann, Susanna Schraen-Maschke, Luc Buée, et al.Multiple Sclerosis and Related Disorders|July 25, 2024
Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: A 6-year follow-upXavier Ayrignac, Safa Aouinti, Thierry Vincent, et al.Journal of Pharmaceutical and Biomedical Analysis|September 21, 2023
Determination of plasma concentration of Belimumab by LC-MS/MS: Method development, validation, and clinical applicationClémence Marin, Gaëlle Noé, Dimitri Schlemmer, et al.Journal of Experimental & Clinical Cancer Research : CR|March 22, 2025
Proteomic profiling and functional analysis of extracellular vesicles from metastasis-competent circulating tumor cells in colon cancerLuis Enrique Cortés-Hernández, Zahra Eslami-S, Aurore Attina, et al.Pageof 15